Administering daily injections of small interfering RNAs for a week was effective in treating four rhesus monkeys that were given high doses of the Ebola virus, according to researchers for the U.S. government and Tekmira Pharmaceuticals. They found that siRNAs control the activity of the virus while waiting for the immune system to take over. The researchers plan to apply for federal financing to further test the technique.

Full Story:

Related Summaries